Article info

Original research
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies

Authors

  1. Correspondence to Dr Nai-Kong V Cheung; cheungn{at}mskcc.org
View Full Text

Citation

Park JA, Cheung NV
Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies

Publication history

  • Accepted December 22, 2021
  • First published January 27, 2022.
Online issue publication 
January 27, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.